<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font20">(.) </span>
   <span class="font18">were </span>
   <span class="font18">drug </span>
   <span class="font17">was </span>
   <span class="font16">HIV </span>
   <span class="font16">PDR </span>
   <span class="font16">resistance </span>
   <span class="font15">with </span>
   <span class="font15">for </span>
   <span class="font14">The </span>
   <span class="font14">transmission </span>
   <span class="font14">from </span>
   <span class="font13">{background </span>
   <span class="font13">prevalence </span>
   <span class="font13">(/) </span>
   <span class="font13">antiretroviral </span>
   <span class="font13">ART </span>
   <span class="font13">study </span>
   <span class="font13">among </span>
   <span class="font12">(.â€".) </span>
   <span class="font12">[]. </span>
   <span class="font12">margin </span>
   <span class="font12">patients </span>
   <span class="font12">{border-style </span>
   <span class="font12">China </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">networks </span>
   <span class="font12">sequences </span>
   <span class="font12">.(/) </span>
   <span class="font12">[], </span>
   <span class="font12">individuals </span>
   <span class="font12">this </span>
   <span class="font11">high </span>
   <span class="font11">(.%) </span>
   <span class="font11">Control </span>
   <span class="font11">mutations </span>
   <span class="font11">regions </span>
   <span class="font11">therapy </span>
   <span class="font11">associated </span>
   <span class="font11">initiating </span>
   <span class="font11">.collab: </span>
   <span class="font11">Center </span>
   <span class="font11">WHO </span>
   <span class="font11">first-line </span>
   <span class="font11">included </span>
   <span class="font11">most </span>
   <span class="font11">that </span>
   <span class="font11">China. </span>
   <span class="font11">Disease </span>
   <span class="font11">Sichuan </span>
   <span class="font11">Antiretroviral </span>
   <span class="font11">Liangshan </span>
   <span class="font11">National </span>
   <span class="font11">all </span>
   <span class="font11">are </span>
   <span class="font11">participants </span>
   <span class="font11">surveillance </span>
   <span class="font11">Dehong </span>
   <span class="font11">Guangxi </span>
   <span class="font11">Pretreatment </span>
   <span class="font11">Title </span>
   <span class="font11">had </span>
   <span class="font11">results </span>
   <span class="font11">subordinate </span>
   <span class="font11">treatment </span>
   <span class="font11">used </span>
   <span class="font11">which </span>
   <span class="font11">(.%, </span>
   <span class="font11">CI: </span>
   <span class="font11">HIV- </span>
   <span class="font11">Liangshan, </span>
   <span class="font11">before </span>
   <span class="font11">contained </span>
   <span class="font11">drugs </span>
   <span class="font11">genetic </span>
   <span class="font11">infected </span>
   <span class="font11">infection </span>
   <span class="font11">not </span>
   <span class="font11">number </span>
   <span class="font11">prefecture </span>
   <span class="font11">px; </span>
   <span class="font11">region </span>
   <span class="font11">related </span>
   <span class="font11">these </span>
   <span class="font11">two </span>
   <span class="font11">who </span>
   <span class="font11">{font-family </span>
   <span class="font10">Dis </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">HIVDR </span>
   <span class="font10">IDUs </span>
   <span class="font10">NNRTI </span>
   <span class="font10">PDR. </span>
   <span class="font10">Prevention </span>
   <span class="font10">Prevention, </span>
   <span class="font10">Yunnan </span>
   <span class="font10">failure </span>
   <span class="font10">font-size </span>
   <span class="font10">mutation </span>
   <span class="font10">pretreatment </span>
   <span class="font10">reverse </span>
   <span class="font10">transcriptase </span>
   <span class="font10">(%) </span>
   <span class="font10">.%), </span>
   <span class="font10">All </span>
   <span class="font10">China, </span>
   <span class="font10">Free </span>
   <span class="font10">However, </span>
   <span class="font10">Infect </span>
   <span class="font10">Lincang </span>
   <span class="font10">NRTI </span>
   <span class="font10">Prefecture </span>
   <span class="font10">Science </span>
   <span class="font10">This </span>
   <span class="font10">Two </span>
   <span class="font10">adults </span>
   <span class="font10">al.Pretreatment </span>
   <span class="font10">analysis </span>
   <span class="font10">cohort </span>
   <span class="font10">data </span>
   <span class="font10">double; </span>
   <span class="font10">factors </span>
   <span class="font10">five </span>
   <span class="font10">has </span>
   <span class="font10">have </span>
   <span class="font10">intercourse </span>
   <span class="font10">moderate </span>
   <span class="font10">network </span>
   <span class="font10">networks. </span>
   <span class="font10">regimen </span>
   <span class="font10">regression </span>
   <span class="font10">subjects </span>
   <span class="font10">total, </span>
   <span class="font10">use </span>
   <span class="font10">virological </span>
   <span class="font10">AIDS/STD </span>
   <span class="font10">Chinese </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">DRMs </span>
   <span class="font10">Protease </span>
   <span class="font10">Province, </span>
   <span class="font10">Shandong </span>
   <span class="font10">below </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">defined </span>
   <span class="font10">grid.. </span>
   <span class="font10">inhibitor </span>
   <span class="font10">initiated </span>
   <span class="font10">initiation </span>
   <span class="font10">logistic </span>
   <span class="font10">obtained </span>
   <span class="font10">performed </span>
   <span class="font10">populations </span>
   <span class="font10">recruited </span>
   <span class="font10">reverse-transcriptase </span>
   <span class="font10">same </span>
   <span class="font10">solid; </span>
   <span class="font10">three </span>
   <span class="font10">transmitted </span>
   <span class="font10">virus </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€ƒOthers </span>
   <span class="font10">(ART) </span>
   <span class="font10">.%) </span>
   <span class="font10">AIDS </span>
   <span class="font10">Among </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Chemother </span>
   <span class="font10">Dehong, </span>
   <span class="font10">Drug </span>
   <span class="font10">Funding </span>
   <span class="font10">HX, </span>
   <span class="font10">IV, </span>
   <span class="font10">LL, </span>
   <span class="font10">NFATP </span>
   <span class="font10">Non-nucleoside </span>
   <span class="font10">Number </span>
   <span class="font10">Province </span>
   <span class="font10">RK, </span>
   <span class="font10">Table </span>
   <span class="font10">Technology </span>
   <span class="font10">Total </span>
   <span class="font10">according </span>
   <span class="font10">after </span>
   <span class="font10">any </span>
   <span class="font10">areas </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">cell </span>
   <span class="font10">common </span>
   <span class="font10">contributed </span>
   <span class="font10">counts </span>
   <span class="font10">courier; </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">distance </span>
   <span class="font10">drug-resistant </span>
   <span class="font10">em; </span>
   <span class="font10">estimate </span>
   <span class="font10">followed </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">inhibitors </span>
   <span class="font10">may </span>
   <span class="font10">mortality </span>
   <span class="font10">multivariate </span>
   <span class="font10">networks, </span>
   <span class="font10">odds </span>
   <span class="font10">other </span>
   <span class="font10">overall </span>
   <span class="font10">people </span>
   <span class="font10">potential </span>
   <span class="font10">previous </span>
   <span class="font10">pt;} </span>
   <span class="font10">rates </span>
   <span class="font10">ratio </span>
   <span class="font10">receiving </span>
   <span class="font10">regions, </span>
   <span class="font10">resistance. </span>
   <span class="font10">sampling </span>
   <span class="font10">school </span>
   <span class="font10">study, </span>
   <span class="font10">than </span>
   <span class="font10">those </span>
   <span class="font10">threshold </span>
   <span class="font10">users </span>
   <span class="font10">â€ƒCRF_BC </span>
   <span class="font10">â€ƒUnknown </span>
   <span class="font10">â€ƒâ€‰ </span>
   <span class="font10">â€ƒâ€‰â‰¥â€‰ </span>
  </p>
 </body>
</html>
